Address inflammatory, cystic, and hormonal acne through sebaceous gland modulation, reducing one of the primary biological drivers of persistent breakouts.
give us a call
212.722.2055
schedule an appointment
212.722.2055
schedule an appointment
Experience advanced, dermatologist-guided acne care with AviClear, an FDA-cleared laser designed to reduce excess sebum production by targeting sebaceous glands at the source. Under the care of board-certified dermatologist Dr. Marie V. Hayag on Manhattan’s Upper East Side, AviClear is integrated into a comprehensive acne management strategy to support long-term control of moderate to severe acne without systemic medication.
Address inflammatory, cystic, and hormonal acne through sebaceous gland modulation, reducing one of the primary biological drivers of persistent breakouts.
Support acne improvement with a non-systemic alternative to oral antibiotics or isotretinoin while preserving skin barrier integrity.
Promote gradual oil regulation and acne recurrence prevention through structured follow-up and dermatologist-guided maintenance care.
AviClear is an FDA-cleared laser acne treatment that selectively targets sebaceous glands responsible for excess oil production. Unlike therapies that focus solely on surface bacteria or exfoliation, AviClear works at the level of oil regulation, a root cause of inflammatory and cystic acne.
Using a 1,726 nm wavelength, AviClear delivers selective photothermolysis to sebaceous glands beneath the skin while preserving surrounding tissue. This targeted approach reduces excess sebum production, helping create an environment less prone to clogged pores and inflammation.
At Marie Hayag MD in New York City, AviClear is never positioned as a device-only solution. Instead, it is incorporated into a dermatologist-guided acne management plan tailored to acne severity, hormonal influences, skin tone considerations, and prior treatment history.
AviClear may be appropriate for:
AviClear is a non-invasive laser treatment designed to reduce sebaceous gland activity through selective photothermolysis. These glands produce sebum, an oily substance that contributes to clogged pores and acne formation.
According to the American Academy of Dermatology, excess sebum production is a central contributor to acne formation, making sebaceous gland modulation a clinically relevant treatment strategy.
By safely modulating sebaceous gland activity, AviClear helps reduce one of the primary biological drivers of acne without requiring systemic medication. This makes it especially appealing for patients who prefer to avoid long-term oral antibiotics or isotretinoin.
Key distinctions:
AviClear represents a science-driven, dermatologist-guided approach to acne care focused on oil regulation rather than temporary suppression of symptoms.
For patients concerned about systemic side effects associated with oral acne medications such as Isotretinoin (commonly known as Accutane), AviClear offers a localized, non-systemic treatment option.
While isotretinoin reduces sebaceous gland activity throughout the body, AviClear targets oil glands directly within the skin using laser energy. This localized approach may reduce reliance on systemic exposure while still addressing a primary biological driver of acne.
Treatment selection depends on acne severity, scarring risk, and overall health history. A consultation ensures the safest and most effective approach.
At our Upper East Side dermatology practice, acne treatment begins with a clinical evaluation by a board-certified dermatologist. AviClear is recommended only when appropriate based on:
For many NYC patients, AviClear serves as a non-systemic alternative to isotretinoin or long-term antibiotics. It may reduce reliance on oral medications while still supporting long-term acne control.
AviClear is often combined with:
This integrated strategy strengthens results while protecting long-term skin health.
Each session is performed in-office using precision laser technology and integrated cooling to enhance comfort and safety.
Treatment Protocol Overview
Visible improvement develops gradually over 8-12 weeks as sebaceous gland activity decreases and inflammatory lesions diminish. Results are not instant but reflect progressive oil regulation and reduction in inflammatory lesions.
Because acne is a chronic condition, ongoing acne management supports continued improvement and recurrence prevention.
AviClear offers a targeted, dermatologist-supervised approach to acne management.
Potential benefits include:
Unlike systemic therapies, AviClear works locally at the level of sebaceous glands without affecting the body systemically. For many Manhattan patients, AviClear represents a structured, dermatologist-supervised pathway toward clearer skin without long-term systemic medication dependence.
A consultation with Dr. Hayag includes evaluation of acne type, severity, hormonal influences, and scarring risk to determine candidacy.
AviClear is delivered in three strategically spaced sessions to promote progressive sebaceous gland modulation.
Over several months, targeted glands produce less sebum, reducing clogged pores and inflammatory breakouts.
A customized maintenance plan supports continued clarity and recurrence prevention.
AviClear may be appropriate for adolescents and adults experiencing:
Because AviClear is FDA-cleared for all skin tones, it may be appropriate for patients with skin of color who require careful energy-based treatment selection to reduce risk of post-inflammatory hyperpigmentation. It is particularly attractive for patients seeking a non-invasive, non-systemic acne treatment in Manhattan.
Patients with certain medical conditions or active infections may require additional evaluation. A consultation ensures safety and appropriateness.
If you are researching AviClear Laser Acne Treatment NYC, our Upper East Side dermatology practice offers physician-guided, evidence-based care for moderate to severe acne. Under the supervision of Dr. Marie V. Hayag, AviClear is integrated into a comprehensive acne management strategy focused on long-term oil regulation and recurrence prevention.
Take the next step toward clearer skin with a non-systemic, FDA-cleared acne laser treatment in Manhattan.
Call 212.722.2055 or book online to schedule your AviClear consultation today.
AviClear reduces sebaceous gland activity to support long-term acne control. Because acne is a chronic condition, maintenance care may still be recommended, but many patients experience sustained improvement after the three-treatment series.
Results develop gradually over 8-12 weeks and may continue improving for several months. Many patients maintain clearer skin long term when AviClear is incorporated into a structured acne management plan.
AviClear is a non-systemic alternative to isotretinoin (Accutane). While both reduce oil production, AviClear works locally within the skin rather than systemically. The best option depends on acne severity, scarring risk, and individual medical history.
Yes. AviClear is FDA-cleared and designed to be safe for all skin tones when performed under physician supervision.
Most patients report mild to moderate discomfort (3-4 out of 10), and integrated cooling enhances comfort during treatment.
The cost of AviClear in NYC varies based on treatment plan and clinical needs. During your consultation, we provide transparent pricing and discuss whether AviClear aligns with your acne management goals.
Book a personalized consultation with Marie Hayag’s expert team and explore AviClear laser acne treatment guided by medical expertise and individualized care.
212.722.2055
Request an appointment